Vanguard Group Inc ownership in GM0N / Globus Medical, Inc.

Globus Medical, Inc.

DE ˙ DB ˙ US3795772082

67,76 € ↑1,60 (2,42%)

2026-06-05
DEL PRIS

Security	DE:GM0N / Globus Medical, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	11,277,722 shares
Ownership	9.54%

2024-02-13 - Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,277,722 shares of Globus Medical, Inc. (DE:GM0N). This represents 9.54 percent ownership of the company. In their previous filing dated 2023-09-11 , Vanguard Group Inc had reported owning 11,283,774 shares, indicating a decrease of -0.05 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2024-02-13	2024-02-13	13G/A	11,283,774	11,277,722	-0.05	9.54	-34.02
2023-09-11	2023-09-11	13G/A	7,332,112	11,283,774	53.90	14.46	52.69
2023-02-09	2023-02-09	13G/A	7,509,907	7,332,112	-2.37	9.47	-0.32
2022-02-10	2022-02-10	13G/A	6,866,253	7,509,907	9.37	9.50	5.44
2021-02-10	2021-02-10	13G/A	7,489,962	6,866,253	-8.33	9.01	-9.90
2020-05-08	2020-05-08	13G/A	7,288,227	7,489,962	2.77	10.00	5.71
2020-02-12	2020-02-12	13G/A	7,026,674	7,288,227	3.72	9.46	2.38
2019-02-11	2019-02-11	13G/A	5,942,727	7,026,674	18.24	9.24	12.82
2018-02-09	2018-02-09	13G/A	5,395,441	5,942,727	10.14	8.19	9.20
2017-02-13	2017-02-13	13G/A	4,759,250	5,395,441	13.37	7.50	12.44
2016-02-10	2016-02-10	13G/A		4,759,250		6.67
2015-02-10	2015-02-10	13G/A		4,291,871		6.08
2014-02-11	2014-02-11	13G		3,499,086		5.31

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	GLOBUS MED	CL A	379577208	10,549,455	-56,292	-0.53	921,073	51.64	0.0134
2025-11-07	2025-09-30	13F	GLOBUS MED	CL A	379577208	10,605,747	-103,146	-0.96	607,391	-3.90	0.0091
2025-08-11	2025-06-30	13F	GLOBUS MED	CL A	379577208	10,708,893	-200,189	-1.84	632,039	-20.85	0.0102
2025-05-09	2025-03-31	13F	GLOBUS MED	CL A	379577208	10,909,082	45,248	0.42	798,545	-11.13	0.0144
2025-02-11	2024-12-31	13F	GLOBUS MED	CL A	379577208	10,863,834	240,218	2.26	898,548	18.23	0.0157
2024-11-13	2024-09-30	13F	GLOBUS MED	CL A	379577208	10,623,616	-50,330	-0.47	760,013	3.96	0.0136
2024-08-13	2024-06-30	13F	GLOBUS MED	CL A	379577208	10,673,946	-280,735	-2.56	731,059	24.41	0.0140
2024-05-10	2024-03-31	13F	GLOBUS MED	CL A	379577208	10,954,681	-323,041	-2.86	587,609	-2.23	0.0116
2024-03-11	2023-12-31	13F/A-1	GLOBUS MED	CL A	379577208	11,277,722	32,220	0.29	600,990	7.64	0.0131
2024-02-14	2023-12-31	13F	GLOBUS MED	CL A	379577208	11,277,722	32,220		600,990		0.0132
2023-12-18	2023-09-30	13F/A-1	GLOBUS MED	CL A	379577208	11,245,502	3,732,959	49.69	558,339	24.83	0.0137
2023-11-14	2023-09-30	13F	GLOBUS MED	CL A	379577208	11,245,502	3,732,959		558,339		0.0137
2023-08-14	2023-06-30	13F	GLOBUS MED	CL A	379577208	7,512,543	-32,207	-0.43	447,297	4.67	0.0106
2023-07-14	2023-03-31	13F/A-1	GLOBUS MED	CL A	379577208	7,544,750	212,638	2.90	427,335	-21.53	0.0109
2023-05-15	2023-03-31	13F	GLOBUS MED	CL A	379577208	7,544,750	212,638		427,335		0.0023
2023-02-10	2022-12-31	13F	GLOBUS MED	CL A	379577208	7,332,112	139,413	1.94	544,556	27.09	0.0148
2022-11-14	2022-09-30	13F	GLOBUS MED	CL A	379577208	7,192,699	-266,429	-3.57	428,470	2.32	0.0126
2022-08-12	2022-06-30	13F	GLOBUS MED	CL A	379577208	7,459,128	53,619	0.72	418,755	-23.36	0.0118
2022-05-13	2022-03-31	13F	GLOBUS MED	CL A	379577208	7,405,509	-104,398	-1.39	546,379	0.77	0.0129
2022-02-14	2021-12-31	13F	GLOBUS MED	CL A	379577208	7,509,907	196,405	2.69	542,215	-3.24	0.0123
2021-11-12	2021-09-30	13F	GLOBUS MED	CL A	379577208	7,313,502	59,824	0.82	560,360	-0.36	0.0139
2021-08-13	2021-06-30	13F	GLOBUS MED	CL A	379577208	7,253,678	155,870	2.20	562,378	28.48	0.0140
2021-05-14	2021-03-31	13F	GLOBUS MED	CL A	379577208	7,097,808	231,555	3.37	437,722	-2.25	0.0118
2021-02-12	2020-12-31	13F	GLOBUS MED	CL A	379577208	6,866,253	192,154	2.88	447,817	35.50	0.0130
2020-11-16	2020-09-30	13F	GLOBUS MED	CL A	379577208	6,674,099	-318,315	-4.55	330,501	-0.93	0.0109
2020-08-14	2020-06-30	13F	GLOBUS MED	CL A	379577208	6,992,414	-476,078	-6.37	333,608	5.03	0.0118
2020-05-15	2020-03-31	13F	GLOBUS MED	CL A	379577208	7,468,492	180,265	2.47	317,635	-25.98	0.0135
2020-02-14	2019-12-31	13F	GLOBUS MED	CL A	379577208	7,288,227	40,545	0.56	429,131	15.82	0.0146
2019-11-14	2019-09-30	13F	GLOBUS MED	CL A	379577208	7,247,682	66,627	0.93	370,501	21.97	0.0137
2019-08-14	2019-06-30	13F	GLOBUS MED	CL A	379577208	7,181,055	31,142	0.44	303,760	-14.02	0.0114
2019-05-15	2019-03-31	13F	GLOBUS MED	CL A	379577208	7,149,913	123,239	1.75	353,278	16.17	0.0139
2019-02-14	2018-12-31	13F	GLOBUS MED	CL A	379577208	7,026,674	291,180	4.32	304,114	-20.45	0.0137
2018-12-13	2018-09-30	13F/A-2	GLOBUS MED	CL A	379577208	6,735,494	219,780	3.37	382,306	16.28	0.0149
2018-11-23	2018-09-30	13F/A-1	GLOBUS MED	CL A	379577208	6,735,494	0		382,306		0.0149
2018-11-14	2018-09-30	13F	GLOBUS MED	CL A	379577208	6,735,494	219,780		382,306
2018-08-14	2018-06-30	13F	GLOBUS MED	CL A	379577208	6,515,714	479,584	7.95	328,783	9.33	0.0138
2018-05-15	2018-03-31	13F	GLOBUS MED	CL A	379577208	6,036,130	93,403	1.57	300,720	23.12	0.0132
2018-02-14	2017-12-31	13F	GLOBUS MED	CL A	379577208	5,942,727	85,057	1.45	244,246	40.30	0.0107
2017-11-14	2017-09-30	13F	GLOBUS MED	CL A	379577208	5,857,670	145,627	2.55	174,089	-8.06	0.0081
2017-08-24	2017-06-30	13F/A-1	GLOBUS MED	CL A	379577208	5,712,043	76,345	1.35	189,355	13.43	0.0093
2017-08-11	2017-06-30	13F	GLOBUS MED	CL A	379577208	5,712,043	76,345		189,355
2017-05-12	2017-03-31	13F	GLOBUS MED	CL A	379577208	5,635,698	240,257	4.45	166,929	24.70	0.0086
2017-02-14	2016-12-31	13F	GLOBUS MED	CL A	379577208	5,395,441	260,106	5.07	133,861	15.49	0.0075
2016-11-14	2016-09-30	13F	GLOBUS MED	CL A	379577208	5,135,335	142,829	2.86	115,904	-2.58	0.0068
2016-08-10	2016-06-30	13F	GLOBUS MED	CL A	379577208	4,992,506	127,738	2.63	118,971	2.97	0.0074
2016-05-13	2016-03-31	13F	GLOBUS MED	CL A	379577208	4,864,768	105,518	2.22	115,537	-12.74	0.0075
2016-02-08	2015-12-31	13F	GLOBUS MED	CL A	379577208	4,759,250	139,123	3.01	132,402	38.71	0.0089
2015-11-12	2015-09-30	13F/A-1	GLOBUS MED	CL A	379577208	4,620,127	89,828	1.98	95,452	-17.92	0.0041
2015-11-12	2015-09-30	13F/A-1	GLOBUS MED	CL A	379577208	4,620,127	89,828		95,452		0.0041
2015-11-12	2015-09-30	13F	GLOBUS MED	CL A	379577208	13,145,579			369,819
2015-08-13	2015-06-30	13F	GLOBUS MED	CL A	379577208	4,530,299	182,754	4.20	116,292	5.98	0.0079
2015-05-15	2015-03-31	13F/A-1	GLOBUS MED	CL A	379577208	4,347,545	55,674	1.30	109,732	7.56	0.0074
2015-05-14	2015-03-31	13F	GLOBUS MED	CL A	379577208	4,347,545			109,732
2015-02-12	2014-12-31	13F	GLOBUS MED	CL A	379577208	4,291,871	78,858	1.87	102,017	23.10	0.0073
2014-11-12	2014-09-30	13F	GLOBUS MED	CL A	379577208	4,213,013	285,970	7.28	82,870	-11.78	0.0065
2014-08-11	2014-06-30	13F	GLOBUS MED	CL A	379577208	3,927,043	232,808	6.30	93,936	-4.37	0.0074
2014-05-13	2014-03-31	13F	GLOBUS MED	CL A	379577208	3,694,235	195,149	5.58	98,230	39.11	0.0083
2014-02-12	2013-12-31	13F	GLOBUS MED	CL A	379577208	3,499,086	339,741	10.75	70,612	28.01	0.0062
2013-11-07	2013-09-30	13F	GLOBUS MED	CL A	379577208	3,159,345	587,827	22.86	55,162	27.23	0.0054
2013-08-13	2013-06-30	13F	GLOBUS MED	CL A	379577208	2,571,518	2,571,518		43,356		0.0046

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.